세계의 흡수성 항균 엔벨로프 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2030년)

The global demand for Absorbable Antibacterial Envelope Market is presumed to reach the market size of nearly USD 71.82 MN by 2030 from USD 35.94 MN in 2022 with a CAGR of 9.04% under the study period 2023-2030.

An absorbable antibacterial envelope is a medical device that reduces the risk of infections in patients undergoing cardiac implant procedures, such as pacemakers or defibrillator implantation. The device is made of a bio-absorbable polymer matrix that contains antibiotics, such as minocycline and rifampin, which are released gradually over a period of several weeks after implantation. The Absorbable Antibacterial Envelope is placed around the implantable device at the time of the procedure and is designed to provide a physical barrier between the device and surrounding tissue. The antibiotics within the envelope are released slowly over time, helping to prevent infection at the site of the implant. The device is typically used in patients who are at a high risk of developing infections, such as those who have previously had infections at the site of a cardiac implant or those who have underlying medical conditions that make them more susceptible to infections. The Absorbable Antibacterial Envelope is an important advancement in the field of cardiac implantation, as infections at the site of the implant can be serious and potentially life-threatening. The use of the envelope can help to reduce the incidence of these infections, leading to better patient outcomes and reduced healthcare costs.

Market Dynamics:

The growing incidence of cardiovascular disease, coupled with an aging population, is driving the demand for cardiac implant procedures. This is driving the demand for absorbable antibacterial envelopes, which are used to prevent infections at the site of the implant. Infections at the site of cardiac implants can be serious and life-threatening. The use of absorbable antibacterial envelopes has been shown to reduce the incidence of these infections, leading to increased demand for these devices. Development of more advanced and effective absorbable antibacterial envelopes are more effective at preventing infections and have fewer side effects than earlier versions. The benefits of absorbable antibacterial envelopes, such as the reduced risk of infection and shorter hospital stays, are becoming increasingly well-known among patients and healthcare providers. This is driving the demand for these devices. Governments around the world are encouraging the adoption of antibacterial medical devices, including absorbable antibacterial envelopes, to reduce the incidence of infections and improve patient outcomes.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of absorbable antibacterial envelope. The growth and trends of absorbable antibacterial envelope industry provide a holistic approach to this study.

Market Segmentation:

This section of the absorbable antibacterial envelope market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

• Cardiac Resynchronization Therapy Defibrillators (CRT-D)
• Implantable Cardioverter Defibrillators (Icd)
• Cardiac Resynchronization Therapy Pacemakers (CRT-P)

By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Absorbable Antibacterial Envelope market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the absorbable antibacterial envelope market include Medtronic plc and Aziyo Biologics, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ABSORBABLE ANTIBACTERIAL ENVELOPE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Application
  • 3.7.2 Market Attractiveness Analysis By End-user
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Cardiac Resynchronization Therapy Defibrillators (CRT-D) Historic and Forecast Sales by Regions
• 6.5 Implantable Cardioverter Defibrillators (ICD) Historic and Forecast Sales by Regions
• 6.6 Cardiac Resynchronization Therapy Pacemakers (CRT-P) Historic and Forecast Sales by Regions

7 . GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-user
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-user
• 7.4 Hospitals Historic and Forecast Sales by Regions
• 7.5 Ambulatory Surgical Centers (ASCs) Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ABSORBABLE ANTIBACTERIAL ENVELOPE COMPANIES

• 9.1. Absorbable Antibacterial Envelope Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF ABSORBABLE ANTIBACTERIAL ENVELOPE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Medtronic plc
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Aziyo Biologics Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies